SBIR/STTR Research Award

Rapid Rewarming Reduction of Cryoprotectant Toxicity and Concentration Employing Magnetic Nanoparticles

Award identifier b32e1e3d7371c7e38eaa56b31f5338940103fd246d9d3a8559e2d751abf7a80dAwarding agency Department of Defense · Defense Health Agency

Award amount

$150,000

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Defense Health Agency
Recipient company
TISSUE TESTING TECHNOLOGIES LLC
Proposal award date
2015-10-01
Contract end date
2016-05-01
UEI
ZSY2J1RRALT5
Solicitation number
2015.1
Topic code
DHP15-014

Research abstract

We will evaluate a novel warming method, developed by our collaborator John Bischof, that promises solution of one of the remaining barriers for banking of large organs and vascularized composite tissues. The method involves radiofrequency and magnetic nanoparticles to obtain rapid uniform electromagnetic rewarming of biological materials instead of warming from the outer boundary using convection warming. The tissue system model for demonstration of feasibility is heart valve tissue containing cardiac muscle, leaflet and artery. The impact of rewarming ice-free vitrified heart valve tissues using this new method will be assessed by assay of the component tissues. Dilutions of the baseline cryoprotectant formulation will be employed to determine the lowest concentrations of cryoprotectants that can be used with this new warming method and provide a model for further protocol development such as evaluation of alternative cryoprotectants. This work will be assisted by revolutionary new analytical techniques that have recently become possible for evaluation of vitrification. We anticipate that this work will maximize the viability of the tissue system components post-preservation by minimizing the risks of vitrification failures due to ice formation and cryoprotectant cytotoxicity. In Phase II this work will be expanded to the heart and/or complex vascularized composite tissues.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

22 SBIR/STTR records share this UEI (2014–2023). Reported award amounts total $9,665,888. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.